| Literature DB >> 31835508 |
Sung-Woo Kim1, Won-Sang Jung1, Wonil Park2, Hun-Young Park1,3.
Abstract
The present study examined the effect of a 12-week combined resistance and aerobic exercise training program on cardiometabolic biomarkers and red blood cell (RBC) hemorheological function in 20 obese older men (mean age: 68.8 ± 0.9 years). Subjects were randomly divided into two groups (exercise intervention [EXP; n = 10] and control [CON; n = 10]). The EXP subjects performed resistance and aerobic exercise training program three times per week for 12 weeks, and the CON subjects maintained their regular lifestyle during the intervention period. Body composition was estimated using bioelectrical impedance analysis equipment. Cardiometabolic biomarkers (glucose, insulin, homeostasis model assessment-estimated insulin resistance (HOMA-IR), HOMA β-cell function, and leptin) and RBC hemorheological parameters (RBC deformability and aggregation) were analyzed. Percent body fat decreased significantly in the EXP group during the intervention period but increased significantly in the CON group. Insulin increased significantly in the CON group over the 12-week period and both insulin and HOMA-IR were significantly higher in the CON group than in the EXP group at post-test. RBC deformability (RBC EI_3Pa) and aggregation (RBC AI_3Pa) improved significantly only in the EXP group. The present study suggests that combined exercise training can be useful for improving cardiometabolic biomarkers and RBC hemorheological parameters in obese older men and may help prevent metabolic syndrome and cardiovascular diseases.Entities:
Keywords: RBC hemorheological parameters; aerobic performance; cardiometabolic biomarkers; combined exercise; obese older men
Mesh:
Substances:
Year: 2019 PMID: 31835508 PMCID: PMC6950327 DOI: 10.3390/ijerph16245020
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Characteristics of the subjects.
| Variables | CON ( | EXP ( | |
|---|---|---|---|
| Age (years) | 68.5 ± 0.85 | 69.1 ± 0.88 | –1.555 |
| Body height (cm) | 165.8 ± 4.82 | 164.1 ± 3.79 | 0.846 |
| Body weight (kg) | 71.6 ± 5.00 | 70.7 ± 3.84 | 0.434 |
| BMI (kg/m2) | 26.0 ± 0.43 | 26.2 ± 0.48 | 0.301 |
| Fat free mass (kg) | 45.4 ± 3.17 | 44.8 ± 2.43 | 0.434 |
| Percent body fat (%) | 32.7 ± 1.78 | 32.4 ± 1.37 | 0.434 |
Values are expressed as mean ± standard deviation. CON = control group, EXP = experimental group, BMI = body mass index.
Changes in body composition before and after the 12-week training program in obese older men.
| Variables | CON | EXP | |||||
|---|---|---|---|---|---|---|---|
| Pre | Post | Pre | Post | Time | Group | Interaction | |
| Body weight (kg) | 71.6 ± 5.00 | 72.3 ± 5.05 | 70.7 ± 3.84 | 69.2 ± 4.09 *** | 1.921 (0.096) | 0.970 (0.051) | 14.229 (0.442) ††† |
| Fat free mass (kg) | 45.4 ± 3.17 | 44.4 ± 3.10 * | 44.8 ± 2.43 | 45.2 ± 2.67 | 2.379 (0.117) | 0.014 (0.001) | 13.994 (0.437) ††† |
| Fat mass (kg) | 23.5 ± 2.97 | 24.9 ± 3.14 ***,### | 22.9 ± 2.23 | 21.1 ± 2.22 *** | 1.063 (0.056) | 3.337 (0.156) | 87.840 (0.830) ††† |
| Percent body fat (%) | 32.7 ± 1.78 | 34.3 ± 1.90 ***,### | 32.4 ± 1.37 | 30.4 ± 1.38 *** | 1.151 (0.060) | 8.577 (0.323) † | 282.897 (0.940) ††† |
Values are expressed as mean ± standard deviation. CON = control group, EXP = experimental group. Significant interaction or main effect, †p < 0.05, ††† p < 0.001. Significant difference between pre- and post-tests, * p < 0.05, *** p < 0.001. Significant difference between CON and EXP groups, ### p < 0.001.
Changes of cardiometabolic biomarkers before and after the 12-week training program in obese older men.
| Variables | CON | EXP | |||||
|---|---|---|---|---|---|---|---|
| Pre | Post | Pre | Post | Time | Group | Interaction | |
| Glucose (mg/dL) | 114.38 ± 12.02 | 116.53 ± 6.63 | 120.04 ± 7.76 | 114.32 ± 7.04 | 0.488 (0.026) | 0.354 (0.019) | 2.383 (0.117) |
| Insulin (µU/mL) | 3.39 ± 0.36 | 3.68 ± 0.19 *,### | 3.43 ± 0.22 | 3.27 ± 0.20 | 0.732 (0.039) | 4.885 (0.213) † | 9.337 (0.342) †† |
| HOMA-IR | 0.97 ± 0.20 | 1.06 ± 0.12 # | 1.02 ± 0.13 | 0.93 ± 0.11 | 0.000 (0.000) | 0.736 (0.039) | 5.179 (0.223) † |
| HOMA-ꞵ | 24.53 ± 3.79 | 24.93 ± 1.71 | 21.85 ± 1.69 | 23.16 ± 2.05 | 1.306 (0.068) | 7.533 (0.295) † | 0.370 (0.020) |
| Leptin (μg/L) | 22.08 ± 8.82 | 19.75 ± 6.53 | 22.56 ± 8.01 | 17.03 ± 7.00 ** | 7.459 (0.293) † | 0.132 (0.007) | 1.232 (0.064) |
Values are expressed as mean ± standard deviation. CON = control group, EXP = experimental group, HOMA-IR = homeostatic model assessment for insulin resistance, HOMA-ꞵ = homeostatic model assessment for ꞵ-cell function. Significant interaction or main effect, † p < 0.05, †† p < 0.01. Significant difference between pre- and post-tests, * p < 0.05, ** p < 0.01. Significant difference between CON and EXP groups, # p < 0.05, ### p < 0.001.
Figure 1RBC hemorheological parameters before and after the 12-week training program. (A) For RBC deformability, statistical analyses reveal an increase between pre- and post-test parameters in the EXP group. (B) For RBC aggregation, statistical analyses reveal a decrease between pre- and post-test parameters in the EXP group. RBC = red blood cell, EI = elongation index, AI = aggregation index, CON = control group, EXP = experimental group. Significant difference between pre- and post-tests, *** p < 0.001. Significant difference between CON and EXP groups, ### p < 0.001.
Figure 2VO2peak before and after the 12-week training program. For aerobic performance, statistical analyses reveal an increase between pre- and post-test in the EXP group. VO2peak = peak oxygen uptake, CON = control group, EXP = experimental group. Significant difference between pre- and post-tests, *** p < 0.001.